Literature DB >> 11747056

Methodological limitations of economic evaluations of antenatal screening.

S Petrou1.   

Abstract

A review of recent economic studies of antenatal screening reveals widespread violation of accepted economic evaluation methodology. In particular, the costs and benefits of antenatal screening are often misclassified and conflated, and the non-resource effects of averted costs are often excluded from the evaluation process. The result is a widespread violation of the explicit and systematic approaches taken by economic analysts more generally, and conclusions that may be described as misleading. This letter calls for economic analysts to be consistent in their application of economic evaluation methodology to antenatal screening programmes. Copyright 2001 John Wiley & Sons, Ltd.

Mesh:

Year:  2001        PMID: 11747056     DOI: 10.1002/hec.636

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  5 in total

1.  Methods for evaluating the benefits and harms of antenatal and newborn screening programmes adopted by health economic assessments: protocol for a systematic review.

Authors:  May Ee Png; Miaoqing Yang; Nia Roberts; Sian Taylor-Phillips; Oliver Rivero-Arias; Stavros Petrou
Journal:  BMJ Open       Date:  2021-08-24       Impact factor: 2.692

Review 2.  Evaluating Cost-effectiveness of Interventions That Affect Fertility and Childbearing: How Health Effects Are Measured Matters.

Authors:  Jeremy D Goldhaber-Fiebert; Margaret L Brandeau
Journal:  Med Decis Making       Date:  2015-04-29       Impact factor: 2.749

3.  Economic evaluation of multiplex ligation-dependent probe amplification and karyotyping in prenatal diagnosis: a cost-minimization analysis.

Authors:  Elisabeth M A Boormans; Erwin Birnie; Mariëtte J V Hoffer; Merryn V E Macville; Robert-Jan Galjaard; Gijsbertha H Schuring-Blom; Shama L Bhola; Karin Huijsdens; Arie Smits; Jan M M van Lith
Journal:  Arch Gynecol Obstet       Date:  2011-05-19       Impact factor: 2.344

4.  Introducing the non-invasive prenatal test for trisomy 21 in Belgium: a cost-consequences analysis.

Authors:  Mattias Neyt; Frank Hulstaert; Wilfried Gyselaers
Journal:  BMJ Open       Date:  2014-11-07       Impact factor: 2.692

5.  An economic analysis of chromosome testing in couples with children who have structural chromosome abnormalities.

Authors:  Kittiphong Thiboonboon; Wantanee Kulpeng; Yot Teerawattananon
Journal:  PLoS One       Date:  2018-06-19       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.